Memorial Sloan Kettering Cancer Center at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Memorial Sloan Kettering Cancer Center brings 5 presentations to ENA 2026 in Barcelona. Its program centres on the RAS pathway, from resistance mechanisms to trapping the ARAF:MEK1 complex, plus AI for drug design. It also reports early phase 1 results for ARV-806, a PROTAC degrader of KRAS G12D, and tumor infiltrating lymphocyte therapy for children and adolescents with melanoma.

OrganizationENA 2026 Attendance
Cancer centres & hospitals
Cancer treatment and research centre with clinical, laboratory and computational research programmes.
Poster
Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Memorial Sloan Kettering Cancer Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction